News | June 21, 2023
Mandaviya inaugurates G20 co-branded event of PMNCH, Geneva on health
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Subscribe To Our Newsletter & Stay Updated
